Literature DB >> 210247

Isolation of a heterogeneous population of temperature-sensitive mutants of measles virus from persistently infected human lymphoblastoid cell lines.

G Ju, S Udem, B Rager-Zisman, B R Bloom.   

Abstract

Two human lymphoblastoid B-cell lines, WI-L2 and 8866, were infected with the Edmonston strain of measles virus at a multiplicity of infection of 10(-6), and stable persistent infections were established. By immunofluorescence and electron microscopy, the vast majority of cells from both cell lines were expressing viral antigens and releasing virion-like particles. However, very little infectious virus could be detected at 37 degrees C, either by an infectious centers assay or by titration of supernates from persistently infected cultures. When cultures were shifted to 31 degrees C, the cells released a population of virus that was temperature-sensitive. Clonal analysis of supernatant virus at 31 degrees C revealed a highly heterogeneous population of temperature-sensitive mutants, differing in plating efficiency ratios, thermolability, and antigen production at the nonpermissive temperature. Factors such as interferon, defective interfering particles, and extracellular virus do not appear to be important in maintaining the persistent carrier state. These studies have important implications for persistent infections of lymphoid cells in vivo, and the slow neurological diseases associated with measles, subacute sclerosing panencephalitis, and multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210247      PMCID: PMC2184313          DOI: 10.1084/jem.147.6.1637

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Temperature-sensitive viruses and the etiology of chronic and inapparent infections.

Authors:  O T Preble; J S Youngner
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

2.  Characterization of rabies viruses recovered from persistently infected BHK cells.

Authors:  A Kawai; S Matsumoto; K Tanabe
Journal:  Virology       Date:  1975-10       Impact factor: 3.616

3.  Antigenic shift of visna virus in persistently infected sheep.

Authors:  O Narayan; D E Griffin; J Chase
Journal:  Science       Date:  1977-07-22       Impact factor: 47.728

4.  Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro.

Authors:  J J Holland; L P Villarreal; R M Welsh; M B Oldstone; D Kohne; R Lazzarini; E Scolnick
Journal:  J Gen Virol       Date:  1976-11       Impact factor: 3.891

5.  Recovery of Paramyxovirus from the jejunum of patients with multiple sclerosis.

Authors:  I Prasad; J D Broome; L P Pertschuk; J Gupta; A W Cook
Journal:  Lancet       Date:  1977-05-28       Impact factor: 79.321

6.  Integration of viral genomes.

Authors:  V M Zhdanov
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

7.  Isolation and preliminary characterization of temperature-sensitive mutants of measles virus.

Authors:  M V Haspel; R Duff; F Rapp
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

8.  Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.

Authors:  A Adams; H Strander; K Cantell
Journal:  J Gen Virol       Date:  1975-08       Impact factor: 3.891

9.  Characterization of measles viruses in establishment of persistent infections in human lymphoid cell line.

Authors:  T Minagawa; T Sakuma; S Kuwajima; T K Yamamoto; H Iida
Journal:  J Gen Virol       Date:  1976-12       Impact factor: 3.891

10.  The role of defective interfering particles in persistent infection of Vero cells by measles virus.

Authors:  B K Rima; W B Davidson; S J Martin
Journal:  J Gen Virol       Date:  1977-04       Impact factor: 3.891

View more
  16 in total

Review 1.  Lymphocyte function and virus infections.

Authors:  A M Denman
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1979

2.  Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines.

Authors:  D Matteucci; M Paglianti; A M Giangregorio; M R Capobianchi; F Dianzani; M Bendinelli
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

3.  Multiple viral mutations rather than host factors cause defective measles virus gene expression in a subacute sclerosing panencephalitis cell line.

Authors:  R Cattaneo; A Schmid; M A Billeter; R D Sheppard; S A Udem
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

4.  Characterization of herpes simplex virus persistence in a human T lymphoblastoid cell line.

Authors:  P J Cummings; R J Lakomy; C R Rinaldo
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

5.  Characterization of four cell lines persistently infected with measles virus.

Authors:  L E Fisher
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.

Authors:  L M Lamontagne; J M Dupuy
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

7.  Isolation and characterization of measles virus intracellular nucleocapsid RNA.

Authors:  S A Udem; K A Cook
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line.

Authors:  J J Schnorr; S Schneider-Schaulies; A Simon-Jödicke; J Pavlovic; M A Horisberger; V ter Meulen
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

9.  Complementation analysis of measles virus mutants isolated from persistently infected lymphoblastoid cell lines.

Authors:  G Ju; M Birrer; S Udem; B R Bloom
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

10.  Persistent measles virus infection enhances major histocompatibility complex class I expression and immunogenicity of murine neuroblastoma cells.

Authors:  J Gopas; D Itzhaky; Y Segev; S Salzberg; B Trink; N Isakov; B Rager-Zisman
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.